234 related articles for article (PubMed ID: 23942766)
1. Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis.
Ciurzyński M; Bienias P; Irzyk K; Kostrubiec M; Bartoszewicz Z; Siwicka M; Stelmaszczyk-Emmel A; Górska E; Demkow U; Pruszczyk P
Clin Rheumatol; 2014 Jan; 33(1):83-9. PubMed ID: 23942766
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis.
Ciurzyński M; Bienias P; Lichodziejewska B; Kurnicka K; Szewczyk A; Glińska-Wielochowska M; Kurzyna M; Błaszczyk M; Liszewska-Pfejfer D; Pruszczyk P
Clin Rheumatol; 2008 Aug; 27(8):991-7. PubMed ID: 18256871
[TBL] [Abstract][Full Text] [Related]
3. Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.
Dimitroulas T; Giannakoulas G; Papadopoulou K; Karvounis H; Dimitroula H; Koliakos G; Karamitsos T; Parcharidou D; Settas L
J Rheumatol; 2010 May; 37(5):993-9. PubMed ID: 20194451
[TBL] [Abstract][Full Text] [Related]
4. Six-minute walk test reflects neurohormonal activation and right ventricular function in systemic sclerosis patients.
Irzyk K; Bienias P; Kostrubiec M; Rymarczyk Z; Bartoszewicz Z; Siwicka M; Stelmaszczyk-Emmel A; Górska E; Demkow U; Pruszczyk P; Ciurzyński M
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):18-23. PubMed ID: 23406664
[TBL] [Abstract][Full Text] [Related]
5. Relationship between interleukin-6 and cardiac involvement in systemic sclerosis.
Jurisic Z; Martinovic-Kaliterna D; Marasovic-Krstulovic D; Perkovic D; Tandara L; Salamunic I; Carevic V
Rheumatology (Oxford); 2013 Jul; 52(7):1298-302. PubMed ID: 23538743
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
Choi HJ; Shin YK; Lee HJ; Kee JY; Shin DW; Lee EY; Lee YJ; Lee EB; Song YW
Clin Rheumatol; 2008 Apr; 27(4):437-42. PubMed ID: 17899307
[TBL] [Abstract][Full Text] [Related]
7. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
[TBL] [Abstract][Full Text] [Related]
8. Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.
Dimitroulas T; Giannakoulas G; Papadopoulou K; Sfetsios T; Karvounis H; Dimitroula H; Parcharidou D; Koliakos G; Garyfallos A; Styliadis I; Settas L
Clin Rheumatol; 2010 Sep; 29(9):957-64. PubMed ID: 20526641
[TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?
Allanore Y; Wahbi K; Borderie D; Weber S; Kahan A; Meune C
Ann Rheum Dis; 2009 Dec; 68(12):1885-9. PubMed ID: 19054819
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
[TBL] [Abstract][Full Text] [Related]
11. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
[TBL] [Abstract][Full Text] [Related]
12. Troponin I and echocardiography in patients with systemic sclerosis and matched population controls.
Nordin A; Svenungsson E; Björnådal L; Elvin K; Larsson A; Jensen-Urstad K
Scand J Rheumatol; 2017 May; 46(3):226-235. PubMed ID: 27601074
[TBL] [Abstract][Full Text] [Related]
13. The role of matrix metalloproteinases in patients with pulmonary hypertension: data from a prospective study.
Marc A; Pop C; Sitar-Taut AV; Budisan L; Berindan-Neagoe I; Pop D
BMC Cardiovasc Disord; 2021 Dec; 21(1):607. PubMed ID: 34930125
[TBL] [Abstract][Full Text] [Related]
14. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
[TBL] [Abstract][Full Text] [Related]
15. Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.
Gu LQ; Zhao L; Zhu W; Li FY; Zhang MJ; Liu Y; Liu JM; Ning G; Zhao YJ
Endocrine; 2011 Jun; 39(3):266-71. PubMed ID: 21387129
[TBL] [Abstract][Full Text] [Related]
16. Subclinical right ventricular dysfunction in intermittent and persistent mildly asthmatic children on tissue Doppler echocardiography and serum NT-proBNP: Observational study.
Ozde C; Dogru M; Ozde Ş; Kayapinar O; Kaya A; Korkmaz A
Pediatr Int; 2018 Nov; 60(11):1024-1032. PubMed ID: 30179288
[TBL] [Abstract][Full Text] [Related]
17. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
[TBL] [Abstract][Full Text] [Related]
19. Relationship between N-terminal B-type natriuretic propeptide and right ventricular performance assessed by tissue Doppler imaging and speckle tracking echocardiography in children after surgical repair of tetralogy of Fallot.
Pietrzak R; Werner B
Kardiol Pol; 2015; 73(1):24-30. PubMed ID: 25764994
[TBL] [Abstract][Full Text] [Related]
20. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
